To Evaluate the Safety of JL18008

NCT07629310 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jecho Biopharmaceuticals Co., Ltd.